Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.505 USD | +1.98% | -8.33% | -25.62% |
May. 23 | Transcript : Theravance Biopharma, Inc. - Special Call | |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
Financials (USD)
Sales 2024 * | 78.81M | Sales 2025 * | 101M | Capitalization | 406M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | 1M | EV / Sales 2024 * | 3.97 x |
Net cash position 2024 * | 93M | Net cash position 2025 * | - | EV / Sales 2025 * | 4.03 x |
P/E ratio 2024 * |
-19.6
x | P/E ratio 2025 * |
40.2
x | Employees | 99 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.45% |
Latest transcript on Theravance Biopharma, Inc.
1 day | -2.46% | ||
1 week | -8.35% | ||
Current month | -1.18% | ||
1 month | -8.55% | ||
3 months | -13.93% | ||
6 months | -20.57% | ||
Current year | -25.80% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 14-05-31 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 14-05-31 |
Eran Broshy
BRD | Director/Board Member | 65 | 14-06-01 |
Director/Board Member | 59 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.03% | 746 M€ | -.--% | - | |
0.02% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 8.31 | -0.36% | 354 256 |
24-05-24 | 8.34 | -2.46% | 344,561 |
24-05-23 | 8.55 | -4.79% | 370,830 |
24-05-22 | 8.98 | -1.54% | 237,245 |
24-05-21 | 9.12 | +0.22% | 494,738 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.80% | 406M | |
+38.51% | 727B | |
+32.00% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+14.72% | 243B | |
+7.65% | 205B | |
-6.01% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- TBPH Stock